Showing results (1131-1140 of 1,221) with videos related to

Sort By:
Pageof 123
JCO Oncology Practice|March 12, 2024
Health Insurance Navigation Tools Intervention: A Pilot Trial Within the Childhood Cancer Survivor StudyElyse R Park, Anne C Kirchhoff, Karen Donelan, et al.
Psycho-Oncology|July 18, 2025
Psychosocial and NF-κB Activity Effects of the Stress Management and Resiliency Training: Relaxation Response Resiliency Program (SMART-3RP) on Patients With MGUS and Smoldering Multiple Myeloma: A Randomized Waitlist Control TrialLucy Finkelstein-Fox, John W Denninger, Leah E Walsh, et al.
Contemporary Clinical Trials|July 23, 2016
Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trialElyse R Park, Jamie S Ostroff, Giselle K Perez, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 29, 2019
Measuring Cigarette Smoking Risk PerceptionsAnnette R Kaufman, Jenny E Twesten, Jerry Suls, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology GroupRajen Mody, Alice L Yu, Arlene Naranjo, et al.
Pediatric Blood & Cancer|April 1, 2018
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trialNavin Pinto, Steven G DuBois, Araz Marachelian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032Alice L Yu, Andrew L Gilman, M Fevzi Ozkaynak, et al.
Pediatric Blood & Cancer|April 11, 2019
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 studySteve E Braunstein, Wendy B London, Susan G Kreissman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Pageof 123